No Picture

Vowing to spark a revolution in small molecule R&D, Vividion equips itself with an extra $82M for the final stretch to the clinic

Vividion Therapeutics has come a long way in the little more than 2 years since the company officially launched with a $45 million A round in early 2017. CEO Diego Miralles has been building his San Diego-based team and banking cash along the way, addi… […]

No Picture
Industry News

Harvard prof Omid Farokhzad heads west, setting up a new Bay Area biotech on a mission to start a revolution in pre-symptomatic disease detection

As a Harvard professor with close ties to MIT?s Bob Langer, Omid Farokhzad has enjoyed a high-profile role in the Boston/Cambridge biotech community, where he?s participated in launching a lineup of startups. And now Farokhzad ? whose accomplishments e… […]